tiprankstipranks
Trending News
More News >
Pharma Foods International Co., Ltd. (JP:2929)
:2929
Japanese Market

Pharma Foods International Co., Ltd. (2929) Ratios

Compare
1 Followers

Pharma Foods International Co., Ltd. Ratios

JP:2929's free cash flow for Q2 2026 was ¥0.82. For the 2026 fiscal year, JP:2929's free cash flow was decreased by ¥ and operating cash flow was ¥<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Jul 25Jul 24Jul 23Jul 22
Liquidity Ratios
Current Ratio
1.03 1.19 1.18 1.13 1.03
Quick Ratio
0.61 0.80 0.89 0.88 0.77
Cash Ratio
0.35 0.45 0.68 0.67 0.39
Solvency Ratio
-0.04 0.05 0.16 0.14 <0.01
Operating Cash Flow Ratio
-0.18 -0.05 0.24 0.25 -0.27
Short-Term Operating Cash Flow Coverage
-0.27 -0.09 0.35 0.33 -0.38
Net Current Asset Value
¥ -136.00M¥ 2.64B¥ 2.29B¥ 928.00M¥ -574.00M
Leverage Ratios
Debt-to-Assets Ratio
0.46 0.39 0.46 0.55 0.54
Debt-to-Equity Ratio
1.52 1.10 1.46 2.09 2.38
Debt-to-Capital Ratio
0.60 0.52 0.59 0.68 0.70
Long-Term Debt-to-Capital Ratio
0.04 0.05 0.10 0.15 0.09
Financial Leverage Ratio
3.30 2.84 3.16 3.76 4.41
Debt Service Coverage Ratio
-0.05 0.09 0.27 0.20 0.01
Interest Coverage Ratio
-5.65 26.03 82.47 75.21 41.54
Debt to Market Cap
0.77 0.50 0.54 0.42 0.40
Interest Debt Per Share
515.09 443.59 596.08 697.59 581.89
Net Debt to EBITDA
50.45 1.14 0.20 0.91 4.07
Profitability Margins
Gross Profit Margin
80.42%80.49%78.45%80.61%79.93%
EBIT Margin
-0.91%3.63%8.20%5.26%2.41%
EBITDA Margin
0.21%4.83%9.66%6.06%3.27%
Operating Profit Margin
-0.91%3.63%8.23%5.26%1.79%
Pretax Profit Margin
-1.12%3.73%8.10%5.17%2.36%
Net Profit Margin
-2.48%0.56%5.16%4.49%-0.62%
Continuous Operations Profit Margin
-2.49%0.56%5.16%4.49%-0.62%
Net Income Per EBT
221.13%15.12%63.67%86.98%-26.28%
EBT Per EBIT
123.70%102.74%98.45%98.12%131.76%
Return on Assets (ROA)
-5.22%1.12%8.76%8.50%-1.20%
Return on Equity (ROE)
-16.46%3.19%27.67%31.99%-5.29%
Return on Capital Employed (ROCE)
-5.82%18.54%38.13%30.44%12.91%
Return on Invested Capital (ROIC)
-2.46%1.45%11.20%10.39%-1.16%
Return on Tangible Assets
-5.24%1.13%8.81%8.56%-1.21%
Earnings Yield
-8.69%1.44%10.24%6.37%-0.88%
Efficiency Ratios
Receivables Turnover
14.74 12.35 14.47 14.97 8.11
Payables Turnover
7.92 6.62 10.72 14.19 10.27
Inventory Turnover
1.44 1.62 1.99 2.20 1.99
Fixed Asset Turnover
14.03 13.90 13.48 15.57 13.50
Asset Turnover
2.10 1.99 1.70 1.89 1.93
Working Capital Turnover Ratio
104.38 16.36 17.10 35.40 15.69
Cash Conversion Cycle
232.46 199.51 174.19 164.86 192.82
Days of Sales Outstanding
24.77 29.56 25.22 24.39 45.03
Days of Inventory Outstanding
253.76 225.10 183.03 166.20 183.33
Days of Payables Outstanding
46.07 55.14 34.06 25.73 35.54
Operating Cycle
278.53 254.66 208.25 190.59 228.36
Cash Flow Ratios
Operating Cash Flow Per Share
-134.04 -37.99 192.89 212.11 -209.04
Free Cash Flow Per Share
-166.27 -68.99 158.68 198.08 -225.31
CapEx Per Share
32.23 31.00 34.21 14.03 16.27
Free Cash Flow to Operating Cash Flow
1.24 1.82 0.82 0.93 1.08
Dividend Paid and CapEx Coverage Ratio
-2.35 -0.65 3.43 6.23 -4.52
Capital Expenditure Coverage Ratio
-4.16 -1.23 5.64 15.12 -12.85
Operating Cash Flow Coverage Ratio
-0.26 -0.09 0.32 0.30 -0.36
Operating Cash Flow to Sales Ratio
-0.06 -0.02 0.09 0.09 -0.10
Free Cash Flow Yield
-25.04%-7.78%14.41%11.82%-15.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-11.51 69.28 9.77 15.71 -113.50
Price-to-Sales (P/S) Ratio
0.28 0.39 0.50 0.71 0.71
Price-to-Book (P/B) Ratio
1.99 2.21 2.70 5.03 6.00
Price-to-Free Cash Flow (P/FCF) Ratio
-3.99 -12.86 6.94 8.46 -6.49
Price-to-Operating Cash Flow Ratio
-4.98 -23.35 5.71 7.90 -7.00
Price-to-Earnings Growth (PEG) Ratio
-1.10 -0.78 1.74 -0.02 1.03
Price-to-Fair Value
1.99 2.21 2.70 5.03 6.00
Enterprise Value Multiple
184.39 9.23 5.42 12.56 25.63
Enterprise Value
26.55B 29.10B 32.54B 52.19B 50.46B
EV to EBITDA
184.39 9.23 5.42 12.56 25.63
EV to Sales
0.39 0.45 0.52 0.76 0.84
EV to Free Cash Flow
-5.50 -14.67 7.21 9.12 -7.72
EV to Operating Cash Flow
-6.82 -26.65 5.93 8.52 -8.32
Tangible Book Value Per Share
332.92 397.67 401.11 325.25 233.23
Shareholders’ Equity Per Share
336.43 401.74 407.33 333.49 243.68
Tax and Other Ratios
Effective Tax Rate
-1.21 0.85 0.36 0.13 1.26
Revenue Per Share
2.34K 2.27K 2.19K 2.37K 2.07K
Net Income Per Share
-58.02 12.80 112.69 106.70 -12.89
Tax Burden
2.21 0.15 0.64 0.87 -0.26
Interest Burden
1.24 1.03 0.99 0.98 0.98
Research & Development to Revenue
0.02 0.02 0.02 0.01 0.01
SG&A to Revenue
0.10 0.18 0.19 0.06 0.06
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.31 -2.97 1.09 1.73 -4.26
Currency in JPY